Qualigen Therapeutics Inc
NASDAQ:QLGN
Qualigen Therapeutics Inc
Common Stock
Qualigen Therapeutics Inc
Common Stock Peer Comparison
Competitive Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Qualigen Therapeutics Inc
NASDAQ:QLGN
|
Common Stock
$43.3k
|
CAGR 3-Years
13%
|
CAGR 5-Years
-65%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Common Stock
$18m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Common Stock
$1m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Common Stock
$33.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
1%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Common Stock
$2.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
3%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Common Stock
$101.8k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Qualigen Therapeutics Inc's Common Stock?
Common Stock
43.3k
USD
Based on the financial report for Dec 31, 2023, Qualigen Therapeutics Inc's Common Stock amounts to 43.3k USD.
What is Qualigen Therapeutics Inc's Common Stock growth rate?
Common Stock CAGR 5Y
-65%
Over the last year, the Common Stock growth was 8%. The average annual Common Stock growth rates for Qualigen Therapeutics Inc have been 13% over the past three years , -65% over the past five years .